SAS | The Power to Know
cq5dam.thumbnail.319.319
White Paper

Are You Ready for Clinical Trial Data Transparency?

What It Means for Your Business – and What’s Needed for a Successful Implementation

About this paper

Consensus is building around the idea that greater access to patient-level clinical data is a good thing – good for science, business and humanity. From a business perspective, pooling data can significantly reduce the cost of drug development while improving the efficiency of clinical trials. It can also lower clinical trial costs by reducing the number of patients needed for new studies. But data sharing and transparency raises new issues and brings a host of new questions, benefits and risks. For example, unless appro­priate safeguards are in place, open access to clinical trial data could compromise patient privacy, enable faulty science, and be a resource-intensive burden for trial sponsors and data stewards. This paper discusses different approaches to successfully implementing clinical trial data transparency while mitigating these risks.

About SAS

SAS is the leader in analytics. Through innovative software and services, SAS empowers and inspires customers around the world to transform data into intelligence. SAS gives you THE POWER TO KNOW®.

SAS Profile이 있으십니까? 이 양식을 자동으로 완성하려면 로그인

*
*
*
*
 
*
 
 
  SAS Institute의  제품 및 서비스 관련 이메일 수신을 동의 하며. 언제든지 수신 거부 링크를 통하여 이메일 수신동의를 철회 할 수 있음을 이해하였습니다.

모든 SAS Korea의 고객 정보는  SAS 개인 정보 보호 정책(Privacy Statement).에 의거하여 관리 및 운영 됩니다.

 
 

Back to Top